NSE shareholding pattern
Symbiotec Pharmalab Limited shareholding pattern
As of the Sep 2026 shareholding pattern (quarter ended 2026-09-30), promoters held 33.28%, FIIs 3.79%, and DIIs 33.17% of Symbiotec Pharmalab Limited (SYMBIOTEC). No earlier quarter-end pattern is on file for Symbiotec Pharmalab Limited, so only the Sep 2026 levels are stated. The table below shows how promoter, FII, DII and public holding has moved quarter by quarter, taken from the NSE shareholding pattern.
Smart Money Report, Q2 FY27: shareholding patterns for the quarter ended 30 Sep 2026
Definition
A shareholding pattern is the quarterly breakdown of who owns a listed company, split across promoters, foreign institutional investors (FII), domestic institutional investors (DII), and the public. Indian companies file it every quarter under SEBI listing rules. Source: NSE shareholding pattern.
Symbiotec Pharmalab Limited shareholding by quarter
| Quarter | Promoter % | FII % | DII % | Public % | Filed |
|---|---|---|---|---|---|
| Sep 2026 | 33.28 | 3.79 | 33.17 | 29.76 | 2026-09-30 |
| Sep 2026 | 33.28 | 2.68 | 27.51 | 36.53 | 2026-09-01 |
Disclosures shown are public regulatory filings. Data may be delayed or incomplete. Smart-money entities may no longer hold positions shown. Not investment advice.
Disclosure overlap on Symbiotec Pharmalab Limited
16 independent managers16 independent managers disclosed positions in Symbiotec Pharmalab Limited within the same window (Jul 11, 2026 – Oct 9, 2026), per filings across sources. Who they are — and each underlying filing — is shown inside Flock.
A count of what was filed, per public regulatory filings. Not investment advice.
Related on Flock
- Smart money moves this filing week (insider trades, bulk deals and stake disclosures from the last 7 days)
- All NSE shareholding patterns (browse every company by name)
- What is a 13F filing? (how the US equivalent disclosure works)
- FII and DII activity, sourced and dated
- Today's NSE and BSE bulk and block deals
- When smart money's filings overlap (multi-entity disclosure overlap, explained)
Frequently asked questions
What is the promoter holding in Symbiotec Pharmalab Limited?
As of the Sep 2026 shareholding pattern, promoters held 33.28% of Symbiotec Pharmalab Limited (SYMBIOTEC). Figures are taken from the NSE shareholding pattern filing dated 2026-09-30 and may change each quarter. Not investment advice.
What is the FII holding in Symbiotec Pharmalab Limited?
Foreign institutional investors held 3.79% of Symbiotec Pharmalab Limited as of the Sep 2026 pattern. Source: NSE shareholding pattern, quarter ended 2026-09-30. Not investment advice.
How often is the shareholding pattern updated?
Listed Indian companies disclose their shareholding pattern every quarter under SEBI's listing rules. Flock re-stamps each page when a new quarterly pattern is filed, so the freshness chip reflects the true age of the latest data.
The Smart Money Digest
A free weekly email of notable disclosure activity — every line with its filing date and source link. No advice, just filings. Unsubscribe anytime.